Literature DB >> 2753390

Release of iron from ferritin by semiquinone, anthracycline, bipyridyl, and nitroaromatic radicals.

H P Monteiro1, G F Vile, C C Winterbourn.   

Abstract

The cytotoxicity of many xenobiotics is related to their ability to undergo redox reactions and iron dependent free radical reactions. We have measured the ability of a number of redox active compounds to release iron from the cellular iron storage protein, ferritin. Compounds were reduced to their corresponding radicals with xanthine oxidase/hypoxanthine under N2 and the release of Fe2+ was monitored by complexation with ferrozine. Ferritin iron was released by a number of bipyridyl radicals including those derived from diquat and paraquat, the anthracycline radicals of adriamycin, daunorubicin and epirubicin, the semiquinones of anthraquinone-2-sulphonate, 1,5 and 2,6-dihydroxyanthraquinone, 1-hydroxyanthraquinone, purpurin, and plumbagin, and the nitroaromatic radicals of nitrofurantoin and metronidazole. In each case, iron release was more efficient than with an equivalent flux of superoxide. Introduction of air decreased the rate of iron release, presumably because the organic radicals reacted with O2 to form superoxide. In air, iron release was inhibited by superoxide dismutase. Semiquinones of menadione, benzoquinone, duroquinone, anthraquinone 1,5 and 2.6-disulphonate, 1,4 naphthoquinone-2-sulphonate and naphthoquinone, when formed under N2, were unable to release ferrin iron. In air, these systems gave low rates of superoxide dismutase-inhibitible iron release. Of the compounds investigated, those with a single electron reduction potential less than that of ferritin were able to release ferritin iron.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753390     DOI: 10.1016/0891-5849(89)90065-8

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

Review 1.  Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibiotics.

Authors:  James H Doroshow
Journal:  Curr Pharm Biotechnol       Date:  2012-08       Impact factor: 2.837

2.  Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.

Authors:  G Minotti; A F Cavaliere; A Mordente; M Rossi; R Schiavello; R Zamparelli; G Possati
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

3.  Oxidative stress by menadione affects cellular copper and iron homeostasis.

Authors:  M Calderaro; E A Martins; R Meneghini
Journal:  Mol Cell Biochem       Date:  1993-09-08       Impact factor: 3.396

4.  The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925.

Authors:  B B Hasinoff; S V Kala
Journal:  Agents Actions       Date:  1993-05

5.  Quinone-enhanced reduction of nitric oxide by xanthine/xanthine oxidase.

Authors:  Pedro Sanchez-Cruz; Antonio E Alegría
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

6.  IS METABOLIC ACTIVATION OF TOPOISOMERASE II POISONS IMPORTANT IN THE MECHANISM OF CYTOTOXICITY?

Authors:  Birandra K Sinha; Ronald P Mason
Journal:  J Drug Metab Toxicol       Date:  2015-07-24

7.  Role of Oxygen and Nitrogen Radicals in the Mechanism of Anticancer Drug Cytotoxicity.

Authors:  Birandra Kumar Sinha
Journal:  J Cancer Sci Ther       Date:  2020-01-24

Review 8.  Diagnostic and therapeutic approach for acute paraquat intoxication.

Authors:  Hyo-wook Gil; Jung-Rak Hong; Si-Hyong Jang; Sae-Yong Hong
Journal:  J Korean Med Sci       Date:  2014-11-04       Impact factor: 2.153

9.  Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines.

Authors:  Yingying Sun; A Ninh Pham; T David Waite
Journal:  J Neurochem       Date:  2016-05-12       Impact factor: 5.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.